Press "Enter" to skip to content

Alembic Pharma gets USFDA nod for overactive bladder treatment drug

The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg.

Original source: https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-gets-usfda-nod-for-overactive-bladder-treatment-drug/69424866?utm_source=RSS&utm_medium=ETRSS

Also Read:   FDA seizes sanitizers worth Rs 50L